MCID: LYM008
MIFTS: 48

Lymphangiosarcoma malady

Categories: Rare diseases, Cancer diseases, Immune diseases, Skin diseases

Aliases & Classifications for Lymphangiosarcoma

About this section

Aliases & Descriptions for Lymphangiosarcoma:

Name: Lymphangiosarcoma 11 13 37 66
Stewart Treves Syndrome 46 37
Skin Lymphangiosarcoma 11 66
Angiosarcoma Associated with Chronic Lymphedema 46
Lymphangiosarcoma of Stewart and Treves 11
 
Lymphangiosarcoma Following Mastectomy 46
Postmastectomy Extremity Angiosarcoma 46
Malignant Lymphangioendothelioma 11
Stewart-Treves Syndrome 11

Classifications:



External Ids:

Disease Ontology11 DOID:2689
NCIt43 C3205, C4490

Summaries for Lymphangiosarcoma

About this section
Wikipedia:69 Lymphangiosarcoma is a rare malignant tumor which occurs in long-standing cases of primary or secondary... more...

MalaCards based summary: Lymphangiosarcoma, also known as stewart treves syndrome, is related to lymphocytes absent and baastrup's syndrome, and has symptoms including pain of lymph node An important gene associated with Lymphangiosarcoma is PROX1 (Prospero Homeobox 1), and among its related pathways are VEGFR3 signaling in lymphatic endothelium and AGE-RAGE signaling pathway in diabetic complications. Affiliated tissues include lymphatic vessels, endothelial and skin, and related mouse phenotypes are liver/biliary system and no phenotypic analysis.

Disease Ontology:11 A lymphatic system cancer that has material basis in endothelial cells located in lymphatic vessels.

Related Diseases for Lymphangiosarcoma

About this section

Diseases related to Lymphangiosarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 105)
idRelated DiseaseScoreTop Affiliating Genes
1lymphocytes absent10.8FLT4, PROX1
2baastrup's syndrome10.8HBA1, PROX1
3sebaceous adenoma10.7F8, HBA1
4gummatous syphilis10.6FLT4, GJC2
5angiosarcoma10.6
6cutaneous leishmaniasis10.6TNF, VEGFA
7tyrobp-related polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy10.6F8, VWF
8tyrosine hydroxylase-deficient dopa-responsive dystonia10.6F8, VWF
9lymphedema10.6
10secondary central precocious puberty10.6F8, VWF
11hydromyelia10.6FLT4, VEGFA
12familial spastic paralysis10.6F8, VWF
13type 2n von willebrand disease10.6F8, VWF
14allain-babin-demarquez syndrome10.5F8, VWF
15thyroid angiosarcoma10.5CD34, HBA1
16von willibrand disease, type 310.5F8, VWF
17orofaciodigital syndrome vii10.5FLT4, PROX1, VEGFC
18orthostatic proteinuria10.5CD34, HBA1
19skin angiosarcoma10.5CD34, HBA1
20leopard syndrome10.5CD34, HBA1
21pleomorphic adenoma10.5CD34, HBA1
22autoimmune polyendocrine syndrome10.5TNF, VEGFA
23cerebral angioma10.5CD34, HBA1
24pediatric infratentorial ependymoma10.4FLT4, GJC2, VEGFC
25pediatric osteosarcoma10.4CD34, HBA1
26lemierre's syndrome10.4LYZ, TNF
27plexiform neurofibroma10.4CD34, DSP
28malignant gastric germ cell tumor10.4HBA1, PROX1, VEGFA
29silicosiderosis10.4FLT4, PROX1, VEGFA
30hyperpituitarism10.4HBA1, LYZ
31tympanosclerosis10.4F8, VWF
32tooth erosion10.4CD34, HBA1
33spindle cell liposarcoma10.4CD34, HBA1
34al gazali aziz salem syndrome10.4LYZ, VWF
35enamel erosion10.3VEGFA, VWF
36acute bilateral depigmentation of the iris10.3TNF, VEGFA
37tropical spastic paraparesis10.3CD34, DSP
38malignant mediastinal neurogenic neoplasm10.3CD34, VWF
39larynx carcinoma in situ10.3TNF, VEGFA, VWF
40wfs1-related disorders10.3F8, VWF
41emphysematous cholecystitis10.3CD34, VEGFA
42renal fibrosis10.3TNF, VEGFA, VWF
43akinetic mutism10.3CD34, HBA1
44bile duct mucoepidermoid carcinoma10.3CD34, VWF
45non-secretory myeloma10.2TNF, VWF
46lymphoid leukemia10.2FLT4, GJC2, PROX1, VEGFC
47amelogenesis imperfecta hypomaturation type10.2MYC, VEGFA
48leptospirosis10.2HBA1, LYVE1, PROX1
49bone marrow cancer10.2CD34, F8, HBA1
50orbital varix10.2FLT4, PDPN

Graphical network of the top 20 diseases related to Lymphangiosarcoma:



Diseases related to lymphangiosarcoma

Symptoms for Lymphangiosarcoma

About this section

UMLS symptoms related to Lymphangiosarcoma:


pain of lymph node

Drugs & Therapeutics for Lymphangiosarcoma

About this section

Drugs for Lymphangiosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
PaclitaxelPhase 2269133069-62-436314
Synonyms:
(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
157069-30-2
33069-62-4
5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.
7-Epi-Paclitaxel
7-Epi-Taxol
7-Epipaclitaxel
7-Epitaxol
7-epi-Paclitaxel
7-epi-Taxol
AB00513812
ABI 007
ABI-007
ABI007
AC-675
AC1L1IOG
AC1L1VJI
AC1L9AVF
ACon1_002231
ANX-513
Abraxane
Abraxane (TN)
Abraxane I.V. Suspension
Abraxis BioScience brand of albumin-bound paclitaxel
Ambotz33069-62-4
Anzatax
Asotax
BIDD:PXR0046
BMS 181339-01
BMS-181339
BMS-181339-01
BPBio1_000320
BRD-A23723433-001-01-2
BRD-A28746609-001-04-0
BRD-K62008436-001-03-1
BSPBio_000290
BSPBio_001152
BSPBio_002614
Bio-0076
Bio1_000362
Bio1_000851
Bio1_001340
Bio2_000416
Bio2_000896
Bristaxol
C07394
C466458
C47H51NO14
CCRIS 8143
CHEBI:103439
CHEBI:45863
CHEMBL100910
CHEMBL418410
CHEMBL48
CID36314
CID441276
CID4666
CID6713921
CID6915727
CPD-8718
Capxol
D00491
DB01229
DHP-107
DHP-208
DRG-0190
DTS-301
DivK1c_000441
EU-0101201
Ebetaxel
EmPAC
Epitaxol
Genaxol
Genetaxyl
Genexol
Genexol-PM
HMS1362J13
HMS1568O12
HMS1792J13
HMS1922K08
HMS1990J13
HMS2090D07
HMS2093K15
HMS501G03
HSDB 6839
I06-0014
IDI1_000441
IDI1_002171
Intaxel
KBio1_000441
KBio2_000492
KBio2_002016
KBio2_002509
KBio2_003060
KBio2_004584
KBio2_005077
KBio2_005628
KBio2_007152
KBio2_007645
KBio3_000903
KBio3_000904
KBio3_001834
KBio3_002987
KBioGR_000492
KBioGR_001893
 
KBioGR_002509
KBioSS_000492
KBioSS_002016
KBioSS_002517
LMPR0104390001
LS-31070
LipoPac
Lopac0_001201
MBT 0206
MEGxp0_001940
MLS000863266
MLS001077297
MLS002154218
MLS002172439
MLS002695976
MPI-5018
Micellar Paclitaxel
Mitotax
MolPort-001-742-627
MolPort-003-665-783
MolPort-003-932-365
NCGC00024995-02
NCGC00024995-03
NCGC00024995-04
NCGC00024995-05
NCGC00024995-06
NCGC00024995-07
NCGC00164367-01
NCGC00164367-02
NCGC00164367-03
NCI60_000601
NINDS_000441
NK 105
NP-010981
NSC 125973
NSC-125973
NSC125973
NSC358882
Nanotaxel
Neuro_000060
Nova-12005
OAS-PAC-100
OncoGel
Onxal
Onxol
Onxol, Taxol, Nov-Onxol, Paclitaxel
P1632
Paclical
Pacligel
Paclitaxel
Paclitaxel (JAN/USP)
Paclitaxel (JAN/USP/INN)
Paclitaxel (Taxol)
Paclitaxel [USAN:INN:BAN]
Paxceed
Paxene
Paxoral
Plaxicel
Praxel
Prestwick0_000155
Prestwick1_000155
Prestwick2_000155
Prestwick3_000155
Probes2_000350
QW 8184
S-8184 Paclitaxel Injectable Emulsion
S1150_Selleck
SDCCGMLS-0066823.P001
SDP-013
SMP1_000228
SMR000394086
SMR000857385
SPBio_000943
SPBio_002229
SPECTRUM1503908
ST50306996
Spectrum2_000872
Spectrum3_001057
Spectrum4_001197
Spectrum5_001491
Spectrum_001536
T 7402
T1912_SIGMA
T7191_SIGMA
T7402_SIGMA
TA1
TAXOL (TN)
TAXOL, 10-EPI,
TXL
TaxAlbin
Taxol
Taxol A
Taxol Konzentrat
Taxol.RTM. (Registered Trademark)
UNII-P88XT4IS4D
UPCMLD-DP108:001
UPCMLD-DP108:002
Vascular Wrap
Xorane
Yewtaxan
abi-007
albumin-bound paclitaxel
cMAP_000068
nab-paclitaxel
nchembio.188-comp1
nchembio.2007.34-comp9
nchembio.215-comp9
nchembio853-comp6
paclitaxel
weekly paclitaxel
2
FluorouracilPhase 1172851-21-83385
Synonyms:
1-fluoro-1h-pyrimidine-2,4-dione
1004-03-1
1upf
2,4-Dihydroxy-5-fluoropyrimidine
2,4-Dioxo-5-fluoropryimidine
2,4-Dioxo-5-fluoropyrimidine
47576_FLUKA
4921-97-5
5 FU Lederle
5 FU medac
5 Fluorouracil
5 Fluorouracil biosyn
5 HU Hexal
5-FU
5-FU (TN)
5-FU Lederle
5-FU medac
5-Faracil
5-Fluor-2,4(1H,3H)-pyrimidindion
5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]
5-Fluor-2,4-dihydroxypyrimidin
5-Fluor-2,4-dihydroxypyrimidin [Czech]
5-Fluor-2,4-pyrimidindiol
5-Fluor-2,4-pyrimidindiol [Czech]
5-Fluoracil
5-Fluoracil [German]
5-Fluoracyl
5-Fluoro-2,4(1H,3H)-pyrimidinedione
5-Fluoro-2,4-pyrimidinedione
5-Fluoropyrimidin-2,4-diol
5-Fluoropyrimidine-2,4-dione
5-Fluorouracil
5-Fluorouracil-biosyn
5-Fluoruracil
5-Fluoruracil [German]
5-Fluracil
5-Ftouracyl
5-HU Hexal
5-fluoro uracil
5-fluoro-1H-pyrimidine-2,4-dione
5-fluoropyrimidine-2,4(1H,3H)-dione
5-fluorouracil
51-21-8
5FU
79108-01-3
AC-11201
AC1L1FTE
AC1Q4N2X
AI3-25297
AKOS000119162
AKOS003237897
AccuSite
Actino-Hermal
Adrucil
Adrucil (TN)
Allergan Brand of Fluorouracil
Arumel
BB_NC-0576
BSPBio_002048
C07649
C4H3FN2O2
CCRIS 2582
CHEBI:46345
CHEMBL185
CID3385
CPD0-1327
CPD000038082
CSP Brand of Fluorouracil
Carac
Carac (TN)
Carzonal
Cinco FU
Cytosafe
D005472
D00584
DB00544
Dakota Brand of Fluorouracil
Dakota, Fluorouracile
Dermatech Brand of Fluorouracil
Dermik Brand of Fluorouracil
DivK1c_000054
EINECS 200-085-6
EU-0100536
Effluderm
Effluderm (free base)
Efudex
Efudix
Efurix
F 6627
F0151
F6627_SIGMA
F8423_SIGMA
FT-0082524
FU
Ferrer Brand of Fluorouracil
Fiverocil
Fluoro Uracil
Fluoro Uracile ICN
Fluoro-Uracile ICN
Fluoro-uracile
Fluoro-uracilo
Fluoroblastin
Fluoroplex
Fluoroplex (TN)
Fluorouracil
Fluorouracil (JP15/USP/INN)
Fluorouracil GRY
Fluorouracil Mononitrate
Fluorouracil Monopotassium Salt
Fluorouracil Monosodium Salt
Fluorouracil Potassium Salt
Fluorouracil Teva Brand
Fluorouracil [USAN:INN:BAN:JAN]
 
Fluorouracil-GRY
Fluorouracile
Fluorouracile Dakota
Fluorouracile [DCIT]
Fluorouracilo
Fluorouracilo Ferrer Far
Fluorouracilo [INN-Spanish]
Fluorouracilum
Fluorouracilum [INN-Latin]
Fluoruracil
Fluouracil
Flurablastin
Fluracedyl
Fluracil
Fluracilum
Fluri
Fluril
Fluro Uracil
Fluroblastin
Flurodex
Flurouracil
Flurox
Ftoruracil
Gry Brand of Fluorouracil
HMS1920O18
HMS2090I04
HMS2091F19
HMS500C16
HSDB 3228
Haemato Brand of Fluorouracil
Haemato fu
Haemato-fu
Hexal Brand of Fluorouracil
I07-0022
ICN Brand of Fluorouracil
IDI1_000054
IN1335
KBio1_000054
KBio2_001321
KBio2_003889
KBio2_006457
KBio3_001268
KBioGR_001253
KBioSS_001321
Kecimeton
LS-153
Lopac-F-6627
Lopac0_000536
MLS000069498
MLS002415705
MolPort-000-156-102
MolPort-003-990-447
MolPort-004-758-143
MolPort-004-758-144
MolPort-005-861-486
NCGC00015442-01
NCGC00015442-03
NCGC00015442-10
NCGC00091349-01
NCGC00091349-02
NCGC00091349-03
NCGC00091349-04
NCGC00091349-05
NCGC00091349-07
NCGC00091349-08
NCI60_001652
NINDS_000054
NSC 19893
NSC-19893
NSC19893
Neocorp Brand of Fluorouracil
Neofluor
Onkofluor
Onkoworks Brand of Fluorouracil
Phthoruracil
Phtoruracil
Queroplex
Ribofluor
Riemser Brand of Fluorouracil
Ro 2-9757
Ro-2-9757
Roche Brand of Fluorouracil
S1209_Selleck
SAM002264615
SMR000038082
SPBio_000291
SPECTRUM1500305
STK297802
Spectrum2_000076
Spectrum3_000434
Spectrum4_000557
Spectrum5_000718
Spectrum_000841
T5233394
TL8006093
Teva Brand of Fluorouracil
Timazin
U 8953
U-8953
UNII-U3P01618RT
UPCMLD-DP130
UPCMLD-DP130:001
URF
Ulup
WLN: T6MVMVJ EF
ZINC00897110
biosyn Brand of Fluorouracil
fluorouracil
inhibits thymilidate synthetase
medac Brand of Fluorouracil
nchembio.90-comp3
nchembio809-comp6
ribosepharm Brand of Fluorouracil
tetratogen
3
BelinostatPhase 142
Synonyms:
 
Belinostat
PXD 101

Interventional clinical trials:

idNameStatusNCT IDPhase
1Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By SurgeryCompletedNCT00217607Phase 2
2Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsCompletedNCT00413322Phase 1

Search NIH Clinical Center for Lymphangiosarcoma


Cochrane evidence based reviews: lymphangiosarcoma

Genetic Tests for Lymphangiosarcoma

About this section

Anatomical Context for Lymphangiosarcoma

About this section

MalaCards organs/tissues related to Lymphangiosarcoma:

34
Endothelial, Skin, Lymph node, Breast, Lung, Cervix, Testes

FMA organs/tissues related to Lymphangiosarcoma:

17
Lymphatic vessels

Animal Models for Lymphangiosarcoma or affiliated genes

About this section

MGI Mouse Phenotypes related to Lymphangiosarcoma:

39
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053708.8FLT4, LYZ, MYC, PROX1, TNF, VEGFA
2MP:00030128.4FLT4, LYZ, MYC, TNF, VEGFA, VWF
3MP:00107717.3CD34, DSP, FLT4, LYZ, MYC, PDPN
4MP:00053816.9DSP, FLT4, LYZ, MYC, PDPN, PROX1
5MP:00053846.7CD34, DSP, GJC2, LYVE1, LYZ, MYC
6MP:00053766.0CD34, F8, FLT4, LYZ, MYC, PDPN
7MP:00053975.9CD34, F8, GJC2, LYVE1, LYZ, MYC
8MP:00107685.8DSP, F8, FLT4, GJC2, LYZ, MYC
9MP:00053855.6DSP, FLT4, LYVE1, LYZ, MYC, PDPN
10MP:00053875.5CD34, F8, FLT4, GJC2, LYVE1, LYZ

Publications for Lymphangiosarcoma

About this section

Articles related to Lymphangiosarcoma:

(show top 50)    (show all 163)
idTitleAuthorsYear
1
Lymphangiosarcoma: Is Stewart-Treves Syndrome a Preventable Condition? (26584023)
2016
2
Stewart-Treves Phenomenon: Lymphangiosarcoma Arising in Lymphedematous Tissue Is Not a Syndrome. (25658055)
2015
3
Presumed primary ocular lymphangiosarcoma with metastasis in a miniature horse. (25581559)
2015
4
Lymphangiosarcoma of the scalp. (24342442)
2014
5
Complex karyotype in a case of cutaneous lymphangiosarcoma associated with chronic lymphedema of the lower limb. (24947410)
2014
6
Lymphangiosarcoma of the scalp. (24636440)
2014
7
Chronic lymphedema of filarial origin: a very rare etiology of cutaneous lymphangiosarcoma. (23372219)
2013
8
Cutaneous lymphangiosarcoma following chronic lymphedema of filarial origin. (23372218)
2013
9
Establishment and characterization of a novel lymphangiosarcoma cell line (MO-LAS) compared with the hemangiosarcoma cell line (ISO-HAS). (23342252)
2012
10
Elevated coagulation factor VIII plasma activity in a patient with lymphangiosarcoma. (23154736)
2012
11
Locally invasive lymphangiosarcoma in a young domestic shorthair. (21880529)
2011
12
Lymphangiosarcoma complicating extensive congenital mixed vascular malformations. (20863270)
2010
13
Case 3. Upper limb lymphangiosarcoma following breast cancer therapy. (16549844)
2006
14
Lymphangiosarcoma in a dog treated with surgery and chemotherapy. (15031550)
2004
15
Cutaneous lymphangiosarcoma in a young dog: clinical, anatomopathological and lectinhistochemical description. (15109239)
2003
16
Metastatic lymphangiosarcoma in a horse. (12009065)
2002
17
Lymphangiosarcoma in a horse. (10805986)
2000
18
Stewart-Treves syndrome: lymphangiosarcoma following mastectomy. (10651369)
2000
19
Lymphangiosarcoma of the pubic region: a rare complication arising in congenital non-hereditary lymphedema. (9854166)
1998
20
Lymphangiosarcoma in a young dog. (8740713)
1996
21
Lymphangiosarcoma following mastectomy. (7586817)
1995
22
Lymphangiosarcoma and haemangiosarcoma in a cat. (2918111)
1989
23
Lymphangiosarcoma in postmastectomy lymphedema (Stewart-Treves syndrome): ultrastructural and immunohistologic characteristics. (2842548)
1988
24
Lymphangiosarcoma complicating chronic primary lymphoedema. (3427373)
1987
25
Lymphangiosarcoma of the hand arising in a pre-existing non-irradiated lymphangioma. (4031613)
1985
26
Lymphangiosarcoma in chronic lymphedema that followed dissection of the groin in surgical management of a malignant melanoma. (6528924)
1984
27
Chemotherapy for postmastectomy lymphangiosarcoma. (7226038)
1981
28
Lymphangiosarcoma of the anterior abdominal wall: a case report. (6452196)
1980
29
Lymphangiosarcoma arising from lymphangioma circumscriptum. (464625)
1979
30
Postmastectomy lymphangiosarcoma: experience with three patients and electron microscopic observations in one. (497934)
1979
31
Lymphangiosarcoma of the lower extermity associated with chronic lymphoedema of filarial origin. (914310)
1977
32
Cutaneous lymphangiosarcoma of Stewart-Treves. (189971)
1976
33
Lymphatics, lymphedema and lymphangiosarcoma. (1096278)
1975
34
Postmastectomy lymphangiosarcoma-temporary response to cyclophosphamide chemotherapy in 2 cases. (4811506)
1974
35
Systemic Chlamydial infection associated with generalized lymphedema and lymphangiosarcoma. (4766275)
1973
36
Lymphangiosarcoma. (16811066)
1972
37
Lymphangiosarcoma arising in chronic congenital and idiopathic lymphoedema. (5094684)
1971
38
Postmastectomy lymphangiosarcoma: ultrastructural observations. (4099693)
1971
39
Lymphangiosarcoma following post-mastectomy lymphedema. (5770234)
1969
40
Surgical treatment of lymphedema and treatment of lymphangiosarcoma. (5377629)
1969
41
Current therapy for postmastectomy lymphangiosarcoma. (5684602)
1968
42
Therapy of lymphangiosarcoma of the chronically edematous limb. Five-year cure of a patient treated by intra-arterial radioactive yttrium. (4289774)
1967
43
Postmastectomy lymphangiosarcoma in a patient with carcinoma of the rectum. (6016731)
1967
44
Lymphangiosarcoma. Report of a case. (5908066)
1966
45
Lymphangiosarcoma in postmastectomy lymphedema. (5866201)
1965
46
Lymphangiosarcoma secondary to chronic lymphedema. (13495828)
1957
47
Lymphangiosarcoma in lymphoedema. (13413767)
1957
48
Lymphangiosarcoma occurring in postmastectomy lymphedema. (13318642)
1956
49
Lymphangiosarcoma of the arm following radical mastectomy. (13269040)
1955
50
Lymphangiosarcoma in the postmastectomy lymphedematous arm. (13258968)
1955

Variations for Lymphangiosarcoma

About this section

Expression for genes affiliated with Lymphangiosarcoma

About this section
Search GEO for disease gene expression data for Lymphangiosarcoma.

Pathways for genes affiliated with Lymphangiosarcoma

About this section

GO Terms for genes affiliated with Lymphangiosarcoma

About this section

Cellular components related to Lymphangiosarcoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1platelet alpha granule lumenGO:00310939.6F8, VEGFA, VEGFC, VWF
2extracellular regionGO:00055767.3CD34, F8, FLT4, HBA1, LYZ, TNF

Biological processes related to Lymphangiosarcoma according to GeneCards Suite gene sharing:

(show all 25)
idNameGO IDScoreTop Affiliating Genes
1lymph vessel developmentGO:000194510.6FLT4, PROX1
2negative regulation of glucose importGO:004632510.4MYC, TNF
3positive regulation of protein complex assemblyGO:003133410.4TNF, VEGFA
4positive regulation of blood vessel endothelial cell migrationGO:004353610.4VEGFA, VEGFC
5blood coagulation, intrinsic pathwayGO:000759710.4F8, VWF
6positive regulation of protein kinase C signalingGO:009003710.4FLT4, VEGFA
7positive regulation of protein autophosphorylationGO:003195410.3VEGFA, VEGFC
8oxygen transportGO:001567110.3HBA1, MYC
9induction of positive chemotaxisGO:005093010.2VEGFA, VEGFC
10positive regulation of endothelial cell migrationGO:001059510.2FLT4, PROX1, VEGFA
11cellular response to vascular endothelial growth factor stimulusGO:003592410.1FLT4, VEGFA
12positive regulation of endothelial cell proliferationGO:000193810.0FLT4, PROX1, VEGFA
13positive regulation of cellular component movementGO:00512729.8PDPN, VEGFA
14lymphangiogenesisGO:00019469.7FLT4, PDPN, PROX1
15positive regulation of angiogenesisGO:00457669.6CD34, VEGFA, VEGFC
16cell motilityGO:00488709.6CD34, PDPN
17platelet degranulationGO:00025769.5F8, VEGFA, VEGFC, VWF
18positive regulation of neuroblast proliferationGO:00020529.5VEGFA, VEGFC
19response to woundingGO:00096119.5LYVE1, MYC, VWF
20positive regulation of epithelial cell proliferationGO:00506799.5MYC, VEGFA, VEGFC
21vascular endothelial growth factor receptor signaling pathwayGO:00480109.4FLT4, VEGFA, VEGFC
22lung developmentGO:00303249.3PDPN, PROX1, VEGFA
23platelet activationGO:00301689.3F8, PDPN, VWF
24single organismal cell-cell adhesionGO:00163378.9CD34, DSP, PDPN
25positive regulation of cell proliferationGO:00082848.8FLT4, MYC, PROX1, VEGFA, VEGFC

Sources for Lymphangiosarcoma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet